Health
Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit – News-Medical.Net
Adding an immune checkpoint inhibitor to anti-HER2 treatment in breast cancer does not improve pathological complete response…
Adding an immune checkpoint inhibitor to anti-HER2 treatment in breast cancer does not improve pathological complete response (pCR), according to the primary analysis of the IMpassion050 trial presented today during the ESMO Virtual Plenary.
The phase III…
Continue Reading
-
Noosa News24 hours agoBrisbane’s covert cameras catching more than just litterbugs
-
Business9 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General19 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News9 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred